2024 MACRA: Quality Measures

EZDERM supports the following 9 Quality measures:

• 47 - Care Plan
• 137 - Melanoma: Continuity of Care - Recall System
• 410 - Psoriasis: Clinical Response to Oral Systemic or Biologic Medications (Outcome measure)
  
• 374 - Closing the referral Loop: Receipt of Specialist Report
• 130- Documentation of Current Medications in the Medical Record
• 176: Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy
• 485: Psoriasis – Improvement in Patient-Reported Itch Severity
• 486: Dermatitis – Improvement in Patient-Reported Itch Severity
• 487: Screening for Social Drivers of Health

Users are alerted in the progress note MACRA Quality wizard whether or not there are some available measures for a visit. Quality measures pertaining to pathology results are also displayed and can be selected from the biopsy review screen (Inbox > Pending Review). Some of these measures are automated, while some require the user to answer Yes or No questions in order to get a point. Patients are asked about one of these measures during EZ Check In (47)

For more information on reporting these measures and our partnership with the data registry Healthmonix, see this article. For steps on how to pull a Quality report through EZDERM, see this article.

Source(s): https://qpp.cms.gov/mips/quality-measures?py=2020